GGrantIndex
← Leaderboards

Bruce A. Berkowitz

Wayne State University

Google Scholar ↗PubMed ↗ORCID ↗
$9,181,136
Attributed
$11,306,307
Total exposure
8
Grants
6
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.6M · FY2007–25
$2M$1.5M$1M$500K$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$11,306,307 · 8

By mechanism

R01$10,483,507 · 6
R21$822,800 · 2

Top collaborators

Most similar at Wayne State University

Same institution · by research overlap

Others in their field

Top investigators on “Alzheimer&Apos”

Research focus

Alzheimer&AposFunctional DisorderIndexingTreatment EfficacyPublic HealthMagnetic Resonance ImagingBiological MarkersMeasurementNeuronsInnovationIn VivoExperimental ModelsEvaluationMitochondriaTissuesImaging BiomarkerImaging ModalityLightPreventExperimental StudyFree RadicalsBaseImpairmentLink

Grant awards (24)

Novel Early Retinal Imaging Biomarkers for Treating Later Spatial Memory Loss in Experimental Alzheimer's Disease$1,064,476
R01 · FY2025 · AG · contact PI
Mitigating retinitis pigmentosa based on a non-invasive rod energy-landscape biomarker$495,426
R01 · FY2025 · EY · contact PI
Novel Early Retinal Imaging Biomarkers for Treating Later Spatial Memory Loss in Experimental Alzheimer's Disease$1,086,200
R01 · FY2024 · AG · contact PI
Mitigating retinitis pigmentosa based on a non-invasive rod energy-landscape biomarker$494,721
R01 · FY2024 · EY · contact PI
Novel Early Retinal Imaging Biomarkers for Treating Later Spatial Memory Loss in Experimental Alzheimer's Disease$1,135,580
R01 · FY2023 · AG · contact PI
Mitigating retinitis pigmentosa based on a non-invasive rod energy-landscape biomarker$501,766
R01 · FY2023 · EY · contact PI
Novel Imaging Biomarker for Treating Spatial Memory Loss in Prodromal Alzheimer's Disease Models$558,744
R01 · FY2021 · AG · contact PI
Novel Imaging Biomarker for Treating Spatial Memory Loss in Prodromal Alzheimer's Disease Models$558,744
R01 · FY2020 · AG · contact PI
Novel Imaging Biomarker for Treating Spatial Memory Loss in Prodromal Alzheimer's Disease Models$558,744
R01 · FY2019 · AG · contact PI
Novel Imaging of rod oxidative stress in retinal disease and treatment in vivo$385,000
R01 · FY2019 · EY · contact PI
Novel Imaging Biomarker for Treating Spatial Memory Loss in Prodromal Alzheimer's Disease Models$558,144
R01 · FY2018 · AG · contact PI
Novel Imaging of rod oxidative stress in retinal disease and treatment in vivo$385,000
R01 · FY2018 · EY · contact PI
Novel Imaging Biomarker for Treating Spatial Memory Loss in Prodromal Alzheimer's Disease Models$599,186
R01 · FY2017 · AG · contact PI
Novel Imaging of rod oxidative stress in retinal disease and treatment in vivo$385,000
R01 · FY2017 · EY · contact PI
Novel Imaging of rod oxidative stress in retinal disease and treatment in vivo$383,959
R01 · FY2016 · EY · contact PI
Role of calcium channels in the development of diabetic retinopathy$223,440
R21 · FY2015 · EY · contact PI
Role of calcium channels in the development of diabetic retinopathy$190,000
R21 · FY2014 · EY · contact PI
Manganese-enhanced MRI Studies of Retinal Neovascularization$221,235
R21 · FY2008 · EY · contact PI
Manganese-enhanced MRI Studies of Retinal Neovascularization$188,125
R21 · FY2007 · EY · contact PI
Retinal Oxygenation in Diabetic Retinopathy$410,672
R01 · FY2004 · EY
Retinal Oxygenation in Diabetic Retinopathy$258,984
R01 · FY2003 · EY
Retinal Oxygenation in Diabetic Retinopathy$242,235
R01 · FY2002 · EY
MR STUDIES OF EXPERIMENTAL RETINOPATHY OF PREMATURITY$215,913
R01 · FY2001 · EY
MR STUDIES OF EXPERIMENTAL RETINOPATHY OF PREMATURITY$205,013
R01 · FY2000 · EY